Thus, these results further confirm that the expansion of glioma cells was enhanced in TNFR2-deficient mice with LPS treatment, which could be due to the inflammatory microenvironment induced by peripheral LPS challenge and loss of TNFR2 signaling. Here, TNFRSF1B is linked to glioma.